Kaiji Fan

Dr. Kaiji Fan

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KFKaiji Fan
Kaiji Fan
JGJan Gravemeyer
Jan Gravemeyer
CRCathrin Ritter
Cathrin Ritter
KRKashif Rasheed
Kashif Rasheed
Thilo GambichlerThilo Gambichler
Thilo Gambichler
Jürgen C. BeckerJürgen C. Becker
Jürgen C. Becker

11 December 2020 in Oncogene
Verified
Journal Article
Open access
PDF file
KFKaiji Fan
Kaiji Fan
ISIvelina Spassova
Ivelina Spassova
JGJan Gravemeyer
Jan Gravemeyer
CRCathrin Ritter
Cathrin Ritter
KHKai Horny
Kai Horny
Jürgen C. BeckerJürgen C. Becker
Jürgen C. Becker
Merkel cell carcinoma (MCC) is a highly invasive and metastatic skin cancer. While high expression of miR-375 is a characteristic of MCC, it seems not to contribute to the malignant phenotype of MCC cells. miR-375 enrichment in MCC-derived extracellular vesicles suggests its intercellular signaling function. Here, we demonstrate that horizontally transferred miR-375 causes fibroblast polarization toward cancer-associated fibroblasts (CAFs). The polarization is evidenced by phenotypic changes and induction ofα-SMA,CXCL2, andIL-1β. Fibroblast polarization is inhibited by specific antagomirs and mimicked by experimental miR-375 expression. Mechanistically, miR-375 downregulatesRBPJandp53, two key players regulating fibroblast polarization. In clinical MCC samples, in situ hybridization located miR-375 in CAFs, which correlated with high α-SMA protein and lowRBPJandTP53expression; single-cell RNAseq revealed a disparate fibroblast polarization negatively correlating with p53 pathway-related gene expression. Thus, the functional role of miR-375 in MCC is to generate a pro-tumorigenic microenvironment by inducing fibroblast polarization.

25 February 2020 in Cancers
Verified
Journal Article
Open access
PDF file
KFKaiji Fan
Kaiji Fan
Armin ZebischArmin Zebisch
Armin Zebisch
KHKai Horny
Kai Horny
DSDavid Schrama
David Schrama
Jürgen C. BeckerJürgen C. Becker
Jürgen C. Becker
MiR-375 is a highly abundant miRNA in Merkel cell carcinoma (MCC). In other cancers, it acts as either a tumor suppressor or oncogene. While free-circulating miR-375 serves as a surrogate marker for tumor burden in patients with advanced MCC, its function within MCC cells has not been established. Nearly complete miR-375 knockdown in MCC cell lines was achieved using antagomiRs via nucleofection. The cell viability, growth characteristics, and morphology were not altered by this knockdown. miR-375 target genes and related signaling pathways were determined using Encyclopedia of RNA Interactomes (ENCORI) revealing Hippo signaling and epithelial to mesenchymal transition (EMT)-related genes likely to be regulated. Therefore, their expression was analyzed by multiplexed qRT-PCR after miR-375 knockdown, demonstrating only a limited change in expression. In summary, highly effective miR-375 knockdown in classical MCC cell lines did not significantly change the cell viability, morphology, or oncogenic signaling pathways. These observations render miR-375 an unlikely intracellular oncogene in MCC cells, thus suggesting that likely functions of miR-375 for the intercellular communication of MCC should be addressed.

22 October 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
KFKaiji Fan
Kaiji Fan
Armin ZebischArmin Zebisch
Armin Zebisch
KHKai Horny
Kai Horny
DSDavid Schrama
David Schrama
Jürgen C. BeckerJürgen C. Becker
Jürgen C. Becker
MiR-375 is a highly abundant miRNA in Merkel cell carcinoma (MCC), in other cancers it acts either as a tumor suppressor or oncogene. While free-circulating miR-375 serves as surrogate marker for tumor burden in patients with advanced MCC, its function within MCC cells has not been established. Nearly complete miR-375 knockdown in MCC cell lines was achieved using antagomiRs via nucleofection. Neither cell viability, growth characteristics nor morphology were altered by this knockdown. miR-375 target genes and related signaling pathways were determined using ENCORI revealing Hippo signaling and EMT-related genes likely to be regulated. Thus, their expression was analyzed by multiplexed qRT-PCR after miR-375 knockdown demonstrating only a limited change in expression. In summary, highly effective miR-375 knockdown in classical MCC cell lines did neither significantly change cell viability, morphology, nor oncogenic signaling pathways. These observations render miR-375 an unlikely intracellular oncogene in MCC cells, thus suggesting to address likely functions of miR-375 for intercellular communication of MCC.